Aspire Biopharma Holdings (ASBP) is scheduled to report Q2 earnings on August 12, 2026.
Analyze the earnings history of Aspire Biopharma Holdings using advanced sorting and filters.
The chart below shows Aspire Biopharma Holdings's reported EPS compared to analyst estimates over recent quarters.
The chart below shows Aspire Biopharma Holdings's reported revenue compared to analyst estimates over recent quarters.
Aspire Biopharma Holdings (ASBP) is scheduled to report earnings on August 12, 2026. The last reported earnings were for reported on May 15, 2026 for Q1.
The Actual EPS was $-20.57, which missed the estimate of $0.00.
The Actual Revenue was $28.35K, which beat the estimate of $0.00.